X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SHASUN PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
SHASUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs94362-   
Low Rs46261-   
Sales per share (Unadj.) Rs214.2107.6-  
Earnings per share (Unadj.) Rs5.3-27.1-  
Cash flow per share (Unadj.) Rs15.8-22.5-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.384.5-  
Shares outstanding (eoy) m56.62168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 11.3%   
Avg P/E ratio x13.1-11.5 -114.1%  
P/CF ratio (eoy) x4.4-13.9 -31.9%  
Price / Book Value ratio x1.33.7 35.5%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,95852,554 7.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1643,298 65.6%   
Avg. sales/employee Rs ThNM4,231.0-  
Avg. wages/employee Rs ThNM768.3-  
Avg. net profit/employee Rs ThNM-1,066.1-  
INCOME DATA
Net Sales Rs m12,12718,164 66.8%  
Other income Rs m229127 180.3%   
Total revenues Rs m12,35618,291 67.6%   
Gross profit Rs m1,009-3,148 -32.1%  
Depreciation Rs m594784 75.7%   
Interest Rs m415492 84.4%   
Profit before tax Rs m230-4,296 -5.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73268 -27.1%   
Profit after tax Rs m302-4,577 -6.6%  
Gross profit margin %8.3-17.3 -48.0%  
Effective tax rate %-31.7-6.2 506.7%   
Net profit margin %2.5-25.2 -9.9%  
BALANCE SHEET DATA
Current assets Rs m6,88413,303 51.7%   
Current liabilities Rs m8,4567,485 113.0%   
Net working cap to sales %-13.032.0 -40.5%  
Current ratio x0.81.8 45.8%  
Inventory Days Days62111 55.6%  
Debtors Days Days108124 86.8%  
Net fixed assets Rs m4,9707,754 64.1%   
Share capital Rs m11384 134.4%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,02014,256 21.2%   
Long term debt Rs m1,8175,010 36.3%   
Total assets Rs m13,34726,932 49.6%  
Interest coverage x1.6-7.7 -20.1%   
Debt to equity ratio x0.60.4 171.2%  
Sales to assets ratio x0.90.7 134.7%   
Return on assets %5.4-15.2 -35.4%  
Return on equity %10.0-32.1 -31.2%  
Return on capital %13.3-19.8 -67.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m3981,550 25.6%  
From Investments Rs m-1,635-476 343.5%  
From Financial Activity Rs m1,3094,547 28.8%  
Net Cashflow Rs m715,621 1.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.99 Rs / ZAR

Compare SHASUN PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: PLETHICO PHARMA  LUPIN LTD  FULFORD INDIA  ORCHID PHARMA LTD  TORRENT PHARMA  



Today's Market

Sensex Opens Higher; Consumer Durables & Bank Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.8% while the Hang Seng is down 0.4%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS